These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37303047)

  • 21. Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.
    Zhao Y; Wang L; Soe MT; Aung PL; Wei H; Liu Z; Ma T; Huang Y; Menezes LJ; Wang Q; Kyaw MP; Nyunt MH; Cui L; Cao Y
    Malar J; 2020 Aug; 19(1):281. PubMed ID: 32758218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.
    Htun MW; Mon NCN; Aye KM; Hlaing CM; Kyaw MP; Handayuni I; Trimarsanto H; Bustos D; Ringwald P; Price RN; Auburn S; Thriemer K
    Malar J; 2017 Jul; 16(1):281. PubMed ID: 28693552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global assessment of genetic paradigms of Pvmdr1 mutations in chloroquine-resistant Plasmodium vivax isolates.
    Spotin A; Mahami-Oskouei M; Ahmadpour E; Parsaei M; Rostami A; Emami S; Gholipour S; Farmani M
    Trans R Soc Trop Med Hyg; 2020 May; 114(5):339-345. PubMed ID: 32100835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).
    Nyunt MH; Han JH; Wang B; Aye KM; Aye KH; Lee SK; Htut Y; Kyaw MP; Han KT; Han ET
    Malar J; 2017 Mar; 16(1):117. PubMed ID: 28298235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India.
    Kaur H; Sehgal R; Kumar A; Bharti PK; Bansal D; Mohapatra PK; Mahanta J; Sultan AA
    BMC Infect Dis; 2020 Sep; 20(1):671. PubMed ID: 32933490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating
    Manh ND; Thanh NV; Quang HH; Van NTT; San NN; Phong NC; Birrell GW; Edgel KA; Martin NJ; Edstein MD; Chavchich M
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0004424. PubMed ID: 39046237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
    Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
    Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Origins of Mutations in the mdr1 Gene--A Putative Marker of Chloroquine Resistance in P. vivax.
    Schousboe ML; Ranjitkar S; Rajakaruna RS; Amerasinghe PH; Morales F; Pearce R; Ord R; Leslie T; Rowland M; Gadalla NB; Konradsen F; Bygbjerg IC; Roper C; Alifrangis M
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004196. PubMed ID: 26539821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.
    Garg S; Saxena V; Lumb V; Pakalapati D; Boopathi PA; Subudhi AK; Chowdhury S; Kochar SK; Kochar DK; Sharma YD; Das A
    Exp Parasitol; 2012 Dec; 132(4):410-6. PubMed ID: 23043980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of drug resistance associated genetic diversity in Mauritanian isolates of Plasmodium vivax reveals limited polymorphism.
    Mint Deida J; Ould Khalef Y; Mint Semane E; Ould Ahmedou Salem MS; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A; Tahar R
    Malar J; 2018 Nov; 17(1):416. PubMed ID: 30409138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of failure of chloroquine treatment for Plasmodium vivax using polymerase chain reaction in Sanliurfa province, Turkey.
    Dilmec F; Kurcer MA; Akkafa F; Simsek Z
    Parasitol Res; 2010 Mar; 106(4):783-8. PubMed ID: 20140453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China.
    Lu F; Wang B; Cao J; Sattabongkot J; Zhou H; Zhu G; Kim K; Gao Q; Han ET
    Korean J Parasitol; 2012 Dec; 50(4):379-84. PubMed ID: 23230341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia.
    Ketema T; Bacha K; Birhanu T; Petros B
    Malar J; 2009 Jul; 8():177. PubMed ID: 19642976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
    Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
    Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.